Table 1.
Baseline Characteristics of the Study Population.
| Overall (N=478) |
No Event Subjects (N=352) |
Event Subjects (N=126) |
P | |
|---|---|---|---|---|
| Age (mean [SD]) | 61 ± 11 | 61 ± 11 | 62 ± 12 | 0.33 |
| Sex (% female) | 159 (33%) | 111 (32%) | 48 (38%) | 0.18 |
| Race (% white) | 355 (74%) | 263 (75%) | 92 (73%) | 0.71 |
| Diabetes (%) | 170 (36%) | 114 (32%) | 56 (44%) | 0.02 |
| Dyslipidemia (%) | 309 (65%) | 227 (65%) | 82 (65%) | 0.91 |
| Renal Disease (%) | 12 (3%) | 5 (1%) | 7 (6%) | 0.02 |
| Current Smoker (%) | 262 (55%) | 188 (53%) | 74 (58%) | 0.30 |
| BMI (mean [SD]) | 30 ± 7 | 30 ± 6 | 30 ± 7 | 0.69 |
| EF (mean [SD]) | 54 ± 14 | 55 ± 14 | 52 ± 15 | 0.03 |
| Number of Diseased Coronary Vessels (mean [SD]) |
2.3 ± 0.8 | 2.3 ± 0.8 | 2.5 ± 0.8 | 0.02 |
| Pre-Procedure Heparin Use (%) |
116 (24%) | 77 (22%) | 39 (31%) | 0.05 |
SD=standard deviation; BMI=body mass index; EF=ejection fraction